Barw Medical Journal

Review Articles Barw Medical Journal. 2025;3(3):46–50

Presentation and Management of Cervical Thoracic Duct Cyst: A Systematic Review of the Literature

ORCID iD for Fahmi H. Kakamad: 0000-0002-2124-9580, , , , , , , , ,

Fahmi H. Kakamad

  • 1College of Medicine, University of Sulaimani, Madam Mitterrand Street, Sulaymaniyah, Iraq

Corresponding author

63 articles in this journal

Dilan S. Hiwa

  • 2Scientific Affairs Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq

13 articles in this journal

Aland S. Abdullah

  • 1College of Medicine, University of Sulaimani, Madam Mitterrand Street, Sulaymaniyah, Iraq

7 articles in this journal

Hiwa O. Baba

  • 2Scientific Affairs Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq

13 articles in this journal

Aso S. Muhialdeen

  • 3Kscien Organization for Scientific Research (Middle East Office), Hamdi Street, Azadi Mall, Sulaymaniyah, Iraq

11 articles in this journal

Sarwat T. San Ahmed

  • 4Sulaymaniyah Teaching Hospital, Sulaymaniyah, Iraq

3 articles in this journal

Mariwan L. Fatah

  • 4Sulaymaniyah Teaching Hospital, Sulaymaniyah, Iraq

3 articles in this journal

Rezheen J. Rashid

  • 5Department of Radiology, Hiwa Cancer Hospital, Shorsh Street, Sulaymaniyah, Iraq

12 articles in this journal

Aras J. Qaradakhy

  • 6Department of Radiology, Shorsh Teaching Hospital, Sulaymaniyah, Iraq

11 articles in this journal

Berun A. Abdalla

  • 2Scientific Affairs Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq

61 articles in this journal

  • 1College of Medicine, University of Sulaimani, Madam Mitterrand Street, Sulaymaniyah, Iraq
  • 2Scientific Affairs Department, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq
  • 3Kscien Organization for Scientific Research (Middle East Office), Hamdi Street, Azadi Mall, Sulaymaniyah, Iraq
  • 4Sulaymaniyah Teaching Hospital, Sulaymaniyah, Iraq
  • 5Department of Radiology, Hiwa Cancer Hospital, Shorsh Street, Sulaymaniyah, Iraq
  • 6Department of Radiology, Shorsh Teaching Hospital, Sulaymaniyah, Iraq

Corresponding author: [email protected] (Fahmi H. Kakamad)

Submitted
20 Apr 2025
Accepted
16 Jun 2025
Published
15 Jun 2025
Reads
1,385
Downloads
241
Citations
1 Citations are Crossref’s count on 8 November 2026.

pp. 46–50 doi:10.58742/bmj.v3i3.189 Open access CC BY 4.0 licence (opens in a new tab)

Download PDF XML

Abstract

IntroductionThoracic duct cysts are an uncommon phenomenon, especially within the cervical region. Due to its limited reported cases, very little is known about its etiology, presentation, and management. This systematic review is conducted to shed light on the ways the cyst presents and the outcomes of different treatment regimens.

MethodsThe EMBASE, CINAHL, PubMed/MEDLINE, Cochrane Library, and Web of Science databases were thoroughly screened to identify any studies published in English up to March 24th, 2024.

ResultsThe average age of the patients was 47.8 years, with 9 (56.3%) females in the study population. The mean size of the cysts was 5.99 cm, and the most common symptom was pain, present in 5 (31.3%) patients. The most common management approach chosen for 6 (37.5%) patients was simple follow-up and observation, followed by surgical excision in 5 (31.3%) patients.

ConclusionPatients with thoracic duct cervical cysts may be asymptomatic or present with pain. Both surgical excision and conservative management may yield satisfactory outcomes.

Keywords Cervical cyst Neck mass Thoracic duct cyst Cervical swelling All subjects

Sections and figures12

Introduction

The thoracic duct runs 38 to 45 centimeters from the cysterna chyli at L2 vertebral level to the lower cervical spine .  The duct is 2 to 5 millimeters wide, and it carries lymph ingested with fat from the vascular bed of the gastrointestinal system and drains into the central veins of the neck . Very rarely, a cyst develops from the thoracic duct, also called a lymphocele of the thoracic duct . The pathology is very uncommon, even more so in the cervical segment, since among the limited reported cases, the majority have been documented as either a thoracic or an abdominal thoracic duct cyst . Although not established, theories suggest that congenital thoracic duct weakness and inflammation-mediated degeneration of the duct can predispose to cyst formation . Due to the limited number of cases reported, no gold standard treatment has been established for cervical thoracic duct cysts; however, both surgical and conservative management have been proposed. To our knowledge, this is the first review in the literature about cervical thoracic duct cysts. This study aims to contribute to the literature by summarizing presentations, management, and outcomes of reported cases of cervical thoracic duct cysts.

Methods

Study design

The guideline followed in this systematic review was that of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Any study with a reported case of a cervical thoracic cyst was included, provided that necessary information was given on the patient and the mass.

Data sources and search strategy

EMBASE, CINAHL, PubMed/MEDLINE, Cochrane Library, and Web of Science databases were all screened using the following ("Thoracic duct" AND Cyst OR Cysts AND Neck OR Cervical) keywords.

Eligibility criteria

Any study with a reported case of thoracic duct cyst found within the cervical region and published in English was deemed eligible. Information on the patient, as well as the characteristics of the cyst, was required. To avoid bias, any study published in predatory journals, identified using Kscien’s list, was excluded from this systematic review .

Study selection process

The titles and abstracts of the enrolled studies were screened by two different researchers, attempting to identify papers based on the study's eligibility criteria. A third researcher was recruited to resolve any disagreements that might arise between the initial two researchers.

Data items

Data was collected on mean age, sex, type of study, country of study, presentation, type of symptoms, location of the cyst, size of the cyst, management, and outcome of each management.

Statistical analysis

Microsoft Excel Workbook sheet was used to record the extracted data. The Statistical Package for Social Sciences (SPSS) 26.0 software was used in further quantitative analysis. The data is presented as frequencies and percentages.

Results

Study selection

The systematic search first brought 39 papers. Out of the initial 39, three only-abstract studies were excluded without further screening. The remaining 36 papers had their titles and abstracts screened, which resulted in 25 papers being removed due to irrelevancy. No paper was excluded due to wrong designs. The remaining 11 studies were checked for wrong outcomes and predatory publishing; however, none were found. This left 11 papers at last to be included in this systematic review. The PRISMA flow chart highlights more details ().

Figure 1. Study selection PRISMA flow chart.

Characteristics of the included studies

Among the 11 included studies, 10 (91%) were case reports, with only one (9%) study being a case series. The United States, with four (36.3%), and France, with two (18.2%) studies, contributed the most, followed by Greece, China, Finland, Norway, and Canada, each with one study.

Main findings

A total of 16 patients were included in this systematic review. The average age of the patients was 47.8 ± 17.8 years. There were nine (56.3%) females compared to six (37.5%) males, leaving one (6.2%) patient unspecified. Half of the patients were symptomatic, and pain was the sole symptom in four (25%) patients. Details on the baseline observation and follow-up of the cyst were done for six (37.5%) patients, followed by surgical excision in five (31.4%) patients, a low-fat diet for two (12.5%) patients, aspiration performed in one (6.2%) patient, and lastly, one (6.2%) patient who underwent both surgical excision and had also received a low-fat diet modification regimen. All (100%) patients had their mass in the left supraclavicular region. The outcome of 12 (75%) patients was to be discharged without complications, whereas one (6.2%) patient was observed to have a persistent mass, and three (18.8%) patients did not have their outcome mentioned ( and 3).

Table 1. Baseline characteristics of the studies included in the analysis.

Author/ year of publication

Type of Study

Country of study

Age (years)

Sex

Presentation

Type of symptoms

Brauchle et al. 2003

Case report

United States

41

Male

Asymptomatic

N/A

Mattila et al. 1999

Case report

Finland

49

Female

Asymptomatic

N/A

Metaxas et al. 2021

Case report

Greece

42

Male

Symptomatic

Pain

Wang et al. 2009

Case report

China

28

Female

Asymptomatic

N/A

Veziant et al. 2015

Case report

France

49

Female

Symptomatic

Pain and Dyspnea

Planchette et al. 2021

Case series

France

50

Male

Asymptomatic

N/A

74

Female

Asymptomatic

N/A

45

Female

Symptomatic

Pain

65

Female

Asymptomatic

N/A

64

Female

Symptomatic

Pain

62

Female

Symptomatic

Pain

Bhalla et al. 2017

Case report

United States

0.67

Male

Symptomatic

Dyspnea

Steinberg 1964

Case report

United States

56

Female

Symptomatic

Migraine headaches

Steinberg & Watson 1966

Case report

United States

28

N/A

Symptomatic

Soreness

Kolbenstvedt et al. 1986

Case report

Norway

55

Male

Asymptomatic

N/A

Wax et al. 1992

Case report

Canada

56

Male

Asymptomatic

N/A

Table 2. Management and outcome of cervical thoracic duct.

Author/ year of publication

Age (years)

Location of cyst

Size of cyst

Management

Outcome

Brauchle et al. 2003

41

   Left supraclavicular

4 cm

Aspiration

Patient was discharged

Mattila et al. 1999

49

Left supraclavicular

3.8 cm

Surgical Excision

Patient was discharged

Metaxas et al. 2021

42

Left Neck

N/A

Surgical Excision

Patient was discharged

Wang et al. 2009

28

Left supraclavicular

10 cm

Surgical Excision

Patient was discharged

Veziant et al. 2015

49

Left supraclavicular

3 cm

Surgical Excision

Patient was discharged

 

 

 

Planchette et al. 2021

50

Left supraclavicular

N/A

Follow up

Patient was discharged

74

Left supraclavicular

N/A

Follow up

Patient was discharged

45

Left supraclavicular

N/A

Follow up

Patient was discharged

65

Left supraclavicular

N/A

Follow up

N/A

64

Left supraclavicular

N/A

Low fat diet

Patient was discharged

62

Left supraclavicular

N/A

Low fat diet

Patient was discharged

Bhalla et al. 2017

0.67

Left supraclavicular

13.1 cm

Surgical drainage and low fat diet

Patient was discharged

Steinberg 1964

56

Left supraclavicular

3 cm

N/A

N/A

Steinberg & Watson 1966

28

Left supraclavicular

3 cm

Follow up

N/A

Kolbenstvedt et al. 1986

55

Left supraclavicular

3 cm

Follow up

Mass persistence

Wax et al. 1992

56

Left supraclavicular

10 cm

Surgical Excision

Patient was discharged

Table 3. Demographic and clinical characteristics of the patients.

Variables

Frequency/percentage

Age (mean ± SD)

   47.8 ± 17.8 years

Sex

   Male

   Female

   N/A

Number of patients (16)

   6 (37.5%)

   9 (56.3%)

   1 (6.2%)

Country of study

   United States

   France

   Greece

   China

   Finland

   Norway

   Canada

Number of studies (11)

   4 (36.3%)

   2 (18.2%)

   1 (9.1%)

   1 (9.1%)

   1 (9.1%)

   1 (9.1%)

   1 (9.1%)

Type of Study

   Case report

   Case series

Number of studies (11)

   10 (90.1%)

   1 (9.9%)

Presentation

   Symptomatic

   Asymptomatic

Number of patients (16)

   8 (50%)

   8 (50%)

Type of symptoms

   Pain

   Pain and dyspnea

   Dyspnea

   Migraine

   Soreness

   N/A

Number of patients (16)

   4 (25%)

   1 (6.2%)

   1 (6.2%)

   1 (6.2%)

   1 (6.2%)

   8 (50%)

Size of cyst (mean ± SD)

   5.99 ± 3.99 cm

Management

   Aspiration

   Surgical Excision

   Follow up

   Low-fat diets

   Surgical excision & low-fat diet

   N/A

Number of patients (16)

   1 (6.2%)

   5 (31.4%)

   6 (37.5%)

   2 (12.5%)

   1 (6.2%)

   1 (6.2%)

Outcome

   Patient was discharged        

   Mass persisted

   N/A

Number of patients (16)

   12 (75%)

   1 (6.2%)

   3 (18.8%)

* N/A: Not applicable

Discussion

Apart from the right side of the upper extremity, the right side of the thorax, and the right side of the neck, the thoracic duct drains the lymphatics of the rest of the body . An uncommon phenomenon related to the duct is a thoracic duct cyst, also called a lymphocele of the thoracic duct . Theoretically, the cyst can arise throughout the length of the entire duct; however, it usually arises within either the thorax or the abdomen. A thoracic lymphocele of the cervical region is the rarest form . A cervical thoracic duct cyst will present as a lateral neck mass arising from the supraclavicular fossa. In this systematic review, all 16 patients presented with a mass, either painful or not, within the left supraclavicular fossa. Bhalla et al. reported the youngest patient recorded in the literature with a thoracic duct lymphocele presenting in an 8-month-old boy . According to Abelarado et al., the cyst tends to occur more frequently in females, and the average age among the patients presenting with the cyst is 49.8 years . This is in accordance with the current study’s findings, as the average age was 47.8 ± 17.8 years, and the majority were females. No single factor has been identified as a cause of this pathology; however, inflammation-mediated degeneration of the duct wall and congenital weakness have been suggested, as well as any possible traumas .

As previously mentioned, since the duct drains the left side of the neck, the cyst will present as a left-sided supraclavicular mass. Most patients with a thoracic duct lymphocele are asymptomatic . Half of the patients in this systematic review were symptomatic, and the other half had no complaints. Symptoms are generally due to the compressive effect of the mass on adjacent structures and can include pain, dysphagia, 

cyanosis, and even respiratory distress . In this study, four (25%) patients presented with pain alone, making it the most common symptom. Others, such as migraine headaches, dyspnea, and soreness, were also reported, with one patient suffering from both pain and dyspnea. Lymphoscintigraphy used to be considered the gold standard for diagnosis; however, with the advent of new high-resolution imaging techniques, this tool has become less popular . Confirmation of the diagnosis is usually conducted during surgery, as histological analysis of the specimen can be beneficial. One way this is done is by staining the endothelial cells lining the thoracic duct to verify that the cyst is, in fact, a thoracic duct cyst . According to Mattila et al., another way to diagnose a thoracic duct cyst is via puncture and subsequence analysis. Following aspiration, the aspirate will manifest as a milky fluid showing excess triglyceride in laboratory investigations and lymphocytes, neutrophils, and macrophages, among others .

Regarding management, no single gold standard has been established. This is attributed to the low number of cases that have been recorded. As previously mentioned, aspiration, although usually performed for diagnosis purposes, can be sufficient to deal with the mass. In this review, only one of the patients had aspiration alone. Surgical excision of the thoracic duct cyst is another common way to manage the mass . This was performed for five (31.4%) patients in this review. Interestingly, in some instances, and especially after deeming the mass nonneoplastic, patients are followed up and observed after they either refuse surgery or the physician doesn’t consider it necessary. This has been highlighted in six (37.5%) patients within this study’s population. Furthermore, patients were managed through diet modification and, more specifically, transitioning to a low-fat diet. This yielded a satisfactory outcome in the two patients who only received diet modification and in the one patient who underwent surgical excision followed by a transition to a low-fat diet. All different management methods yielded satisfactory outcomes, with patients discharged without complications in three-quarters of the cases. This was apart from one patient whose mass persisted since they underwent no management and were observed.

Conclusion

Patients with thoracic duct cervical cysts may be asymptomatic or present with pain. Both surgical excision and conservative management may yield satisfactory outcomes.

Declarations

Conflicts of interest
The authors have no conflicts of interest to disclose.
Ethical approval
Not applicable, as systematic reviews do not require ethical approval.
Patient consent (participation and publication)
Not applicable.
Funding
The present study received no financial support.
Acknowledgements
None to be declared.
Authors' contributions
FHK and BAA were significant contributors to the conception of the study and the literature search for related studies. DSH and ASA involved in the literature review, study design, and manuscript writing. AJQ, RJR, MLF, STSA, ASM, and HOB were involved in the literature review, the study's design, the critical revision of the manuscript, and data collection. FHK and DSH confirm the authenticity of all the raw data. All authors approved the final version of the manuscript.
Use of AI
ChatGPT-3.5 was used to assist in language editing and improving the clarity of the manuscript. All content was reviewed and verified by the authors. Authors are fully responsible for the entire content of their manuscript.
Data availability statement
Not applicable.

References18

  1. Ilahi, Maira, et al. “Anatomy, Thorax, Thoracic Duct.” PubMed, StatPearls Publishing, 2022, pubmed.ncbi.nlm.nih.gov/30020599/. 2023. doi:N/A

    Cited in IntroductionDiscussion

    CrossrefPubMedGoogle Scholar

  2. Phang K, Bowman M, Phillips A, Windsor J. Review of thoracic duct anatomical variations and clinical implications. Clinical anatomy. 2014 ;27(4):637-44. doi:10.1002/ca.22337

    Cited in Introduction

    10.1002/ca.22337CrossrefPubMedScopusGoogle Scholar

  3. Offiah CE, Twigg S. Lymphocoele of the thoracic duct: a cause of left supraclavicular fossa. The British journal of radiology. 2011 ;84(998):e27-30. doi:10.1259/bjr/28200085

    Cited in IntroductionDiscussion

    10.1259/bjr/28200085CrossrefPubMedScopusGoogle Scholar

  4. Brauchle RW, Risin SA, Ghorbani RP, Pereira KD. Cervical thoracic duct cysts: a case report and review of the literature. Archives of Otolaryngology–Head & Neck Surgery. 2003;129(5):581-3. doi:10.1001/archotol.129.5.581

    Cited in IntroductionResultsDiscussion

    10.1001/archotol.129.5.581CrossrefPubMedScopusGoogle Scholar

  5. Farouk A, Weerakkody Y, Bell D, et al. Lymphocele of the thoracic duct. Reference article, Radiopaedia.org. doi:10.53347/rID-56163

    Cited in IntroductionDiscussion

    10.53347/rID-56163CrossrefPubMedScopusGoogle Scholar

  6. Muhialdeen AS, Ahmed JO, Baba HO, Abdullah IY, Hassan HA, Najar KA, Mikael TM, Mustafa MQ, Mohammed DA, Omer DA, Bapir R. Kscien’s list; a new strategy to discourage predatory journals and publishers (second version). Barw Medical Journal. 2023. doi:10.58742/bmj.v1i1.14

    Cited in Methods

    10.58742/bmj.v1i1.14CrossrefPubMedScopusGoogle Scholar

  7. Mattila PS, Tarkkanen J, Mattila S. Thoracic duct cyst: a case report and review of 29 cases. Annals of Otology, Rhinology & Laryngology. 1999 ;108(5):505-8. doi:10.1177/000348949910800516

    Cited in ResultsDiscussion

    10.1177/000348949910800516CrossrefPubMedScopusGoogle Scholar

  8. Metaxas EK, Noussi G. THORACIC DUCT CYST IN THE LE REPORT AND LITE. doi:10.24941/ijcr.41442.06.2021

    Cited in Results

    10.24941/ijcr.41442.06.2021CrossrefPubMedScopusGoogle Scholar

  9. Wang YA, Zhang ZY, Zheng JW, Ye WM, Wang LZ, Zhu HG. Spontaneous thoracic duct cyst presenting as a left supraclavicular mass–report of a case and review of literature. Phlebology. 2009 ;24(2):82-4. doi:10.1258/phleb.2008.008056

    Cited in Results

    10.1258/phleb.2008.008056CrossrefPubMedScopusGoogle Scholar

  10. Veziant J, Sakka L, Galvaing G, Tardy MM, Cassagnes L, Filaire M. Lymphovenous anastomosis for recurrent swelling syndrome and chylous effusion due to cervical thoracic duct cyst. Journal of Vascular Surgery. 2015 ;62(4):1068-70. doi:10.1016/j.jvs.2014.02.060

    Cited in Results

    10.1016/j.jvs.2014.02.060CrossrefPubMedScopusGoogle Scholar

  11. Planchette J, Jaccard C, Nigron A, Chadeyras JB, Le Guenno G, Castagne B, et al. Recurrent thoracic duct cyst of the left supraclavicular fossa: A retrospective study of 6 observational case series and literature review. Medicine. 2021 ;100(50):e28213. doi:10.1097/md.0000000000028213

    Cited in Results

    10.1097/md.0000000000028213CrossrefPubMedScopusGoogle Scholar

  12. Bhalla V, Schrepfer T, McCann A, Nicklaus P, Reading B. Spontaneous retropharyngeal and mediastinal thoracic duct cyst in an infant with respiratory distress. International journal of pediatric otorhinolaryngology. 2018 ;105:33-5. doi:10.1016/j.ijporl.2017.11.021

    Cited in ResultsDiscussion

    10.1016/j.ijporl.2017.11.021CrossrefPubMedScopusGoogle Scholar

  13. Steinberg I. Roentgen diagnosis of persistent jugular lymph sac. Radiology. 1964 ;82(6):1022-3. doi:10.1148/82.6.1022

    Cited in Results

    10.1148/82.6.1022CrossrefPubMedScopusGoogle Scholar

  14. Steinberg I, Watson RC. Lymphangiographic and angiographic diagnosis of persistent jugular lymph sac: report of a case. New England Journal of Medicine. 1966 ;275(26):1471-4. doi:10.1056/nejm196612292752604

    Cited in Results

    10.1056/nejm196612292752604CrossrefPubMedScopusGoogle Scholar

  15. Kolbenstvedt A, Aanesen J. Cystic dilatation of the thoracic duct presenting as a supraclavicular mass. The British Journal of Radiology. 1986 ;59(708):1228-9. doi:10.1259/0007-1285-59-708-1228

    Cited in ResultsDiscussion

    10.1259/0007-1285-59-708-1228CrossrefPubMedScopusGoogle Scholar

  16. Wax MK, Treloar ME. Thoracic duct cyst: an unusual supraclavicular mass. Head & neck. 1992 ;14(6):502-5. doi:10.1002/hed.2880140615

    Cited in Results

    10.1002/hed.2880140615CrossrefPubMedScopusGoogle Scholar

  17. Dortch JD, Eck DL, Hakaim AG, Casler JD. Management of cervical thoracic duct cyst with cyst-venous anastomosis. International Journal of Surgery Case Reports. 2014 ;5(12):1028-30. doi:10.1016/j.ijscr.2014.10.012

    Cited in Discussion

    10.1016/j.ijscr.2014.10.012CrossrefPubMedScopusGoogle Scholar

  18. Chen F, Bando T, Hanaoka N, Terada Y, Ike O, Wada H, et al. Mediastinal thoracic duct cyst. Chest. 1999 ;115(2):584-5. doi:10.1378/chest.115.2.584

    Cited in Discussion

    10.1378/chest.115.2.584CrossrefPubMedScopusGoogle Scholar

Copyright © 2025 The Author(s)

  • Surgical Outcomes Following First Rib Resection for Neurogenic Thoracic Outlet Syndrome: A Systematic Review of 1,334 Operated Sides

    Fahmi H. Kakamad, Saywan K. Asaad, Sanaa O. Karim, Abdullah K. Ghafour, Hiwa S. Namiq, Hawkar A. Nasralla, Lawand A. Sharif, Choman S. Omer and 5 more

    Introduction Neurogenic thoracic outlet syndrome (NTOS) is the most common subtype of thoracic outlet syndrome and results from compression of the brachial plexus within the thoracic outlet. First rib resection (FRR) is considered the cornerstone of surgical management in patients with refractory symptoms, although…

    2026 1,991 reads 0 citations

    doi:10.58742/bmj.v4i1.234

    Full text PDF XML

  • Non-Recommended Publishing Lists: Strategies for Detecting Deceitful Journals

    Fahmi H. Kakamad, Shvan H. Mohammed, Berun A. Abdalla, Dahat A. Hussein, Zuhair D. Hammood, Suhaib H. Kakamad, Diyar A. Omar, Kayhan A. Najar and 6 more

    The rapid growth of open access publishing (OAP) has significantly improved the accessibility and dissemination of scientific knowledge. However, this expansion has also contributed to the emergence of non-recommended journals (NRJs) and non-recommended publishers (NRPs) that exploit researchers by offering rapid…

    2026 2,535 reads 17 citations

    doi:10.58742/bmj.v4i1.227

    Full text PDF XML

  • Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials

    Rebaz M. Ali, Karukh K. Mohammed, Sasan M. Ahmed, Kayhan A. Najar, Mohammed Q. Mustafa, Zanyar K. Hama, Shadan A. Hamad, Maria A. Rasool and 4 more

    Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCLC) after progression on platinum-based therapy. This meta-analysis evaluated the efficacy and safety of tarlatamab as monotherapy and in combination…

    2025 5,636 reads 1 citation

    doi:10.58742/bmj.v4i1.216

    Full text PDF XML

PDF